139 related articles for article (PubMed ID: 8386233)
1. Reversal of gallium arsenide-induced suppression of the antibody-forming cell response by vehicle supernatants. I. Pharmacokinetics after in vitro and in vivo exposure.
Burns LA; Munson AE
J Pharmacol Exp Ther; 1993 Apr; 265(1):144-9. PubMed ID: 8386233
[TBL] [Abstract][Full Text] [Related]
2. Reversal of gallium arsenide-induced suppression of the antibody-forming cell response by vehicle supernatants. II. Nature and identification of reversing factors.
Burns LA; Munson AE
J Pharmacol Exp Ther; 1993 Apr; 265(1):150-8. PubMed ID: 8474002
[TBL] [Abstract][Full Text] [Related]
3. Reversal of gallium arsenide-induced suppression of the antibody response by a mixed disulfide metabolite of meso-2,3-dimercaptosuccinic acid.
Burns LA; Butterworth LF; Munson AE
J Pharmacol Exp Ther; 1993 Feb; 264(2):695-700. PubMed ID: 8382280
[TBL] [Abstract][Full Text] [Related]
4. Evidence for arsenic as the immunosuppressive component of gallium arsenide.
Burns LA; Sikorski EE; Saady JJ; Munson AE
Toxicol Appl Pharmacol; 1991 Aug; 110(1):157-69. PubMed ID: 1651571
[TBL] [Abstract][Full Text] [Related]
5. Splenic cell targets in gallium arsenide-induced suppression of the primary antibody response.
Sikorski EE; Burns LA; Stern ML; Luster MI; Munson AE
Toxicol Appl Pharmacol; 1991 Aug; 110(1):129-42. PubMed ID: 1871769
[TBL] [Abstract][Full Text] [Related]
6. Gallium arsenide selectively inhibits T cell proliferation and alters expression of CD25 (IL-2R/p55).
Burns LA; Munson AE
J Pharmacol Exp Ther; 1993 Apr; 265(1):178-86. PubMed ID: 8097242
[TBL] [Abstract][Full Text] [Related]
7. Arsenic in the sera of gallium arsenide-exposed mice inhibits bacterial growth and increases host resistance.
Burns LA; McCay JA; Brown R; Munson AE
J Pharmacol Exp Ther; 1993 May; 265(2):795-800. PubMed ID: 8496824
[TBL] [Abstract][Full Text] [Related]
8. Gallium arsenide-induced increase in serum corticosterone is not responsible for suppression of the IgM antibody response.
Burns LA; Spriggs TL; Fuchs BA; Munson AE
J Pharmacol Exp Ther; 1994 Feb; 268(2):740-6. PubMed ID: 7509391
[TBL] [Abstract][Full Text] [Related]
9. Suppression of splenic accessory cell function in mice exposed to gallium arsenide.
Sikorski EE; Burns LA; McCoy KL; Stern M; Munson AE
Toxicol Appl Pharmacol; 1991 Aug; 110(1):143-56. PubMed ID: 1714636
[TBL] [Abstract][Full Text] [Related]
10. Gallium arsenide selectively suppresses antigen processing by splenic macrophages for CD4+ T cell activation.
Lewis TA; Munson AE; McCoy KL
J Pharmacol Exp Ther; 1996 Sep; 278(3):1244-51. PubMed ID: 8819508
[TBL] [Abstract][Full Text] [Related]
11. Combined administration of oxalic acid, succimer and its analogue for the reversal of gallium arsenide-induced oxidative stress in rats.
Flora SJ; Kannan GM; Pant BP; Jaiswal DK
Arch Toxicol; 2002 Jun; 76(5-6):269-76. PubMed ID: 12107644
[TBL] [Abstract][Full Text] [Related]
12. Direct exposure to gallium arsenide upregulates costimulatory activity of murine macrophages.
Caffrey-Nolan RE; McCoy KL
Toxicol Appl Pharmacol; 1998 Aug; 151(2):330-9. PubMed ID: 9707509
[TBL] [Abstract][Full Text] [Related]
13. Co-administration of meso 2,3-dimercaptosuccinic acid monoesters reduces arsenic concentration and oxidative stress in gallium arsenide exposed rats.
Flora SJ; Bhatt K; Dwivedi N; Pachauri V; Kushwah PK
Clin Exp Pharmacol Physiol; 2011 Jul; 38(7):423-9. PubMed ID: 21501211
[TBL] [Abstract][Full Text] [Related]
14. Suppression of the vitro humoral immune response of mouse splenocytes by benzo(a)pyrene metabolites and inhibition of benzo(a)pyrene-induced immunosuppression by alpha-naphthoflavone.
Kawabata TT; White KL
Cancer Res; 1987 May; 47(9):2317-22. PubMed ID: 3567925
[TBL] [Abstract][Full Text] [Related]
15. In vitro solubility and in vivo toxicity of gallium arsenide.
Webb DR; Sipes IG; Carter DE
Toxicol Appl Pharmacol; 1984 Oct; 76(1):96-104. PubMed ID: 6484996
[TBL] [Abstract][Full Text] [Related]
16. Gallium arsenide exposure impairs processing of particulate antigen by macrophages: modification of the antigen reverses the functional defect.
Hartmann CB; McCoy KL
Life Sci; 2004 Jun; 75(4):485-98. PubMed ID: 15147834
[TBL] [Abstract][Full Text] [Related]
17. Immunotoxicity of the semiconductor gallium arsenide in female B6C3F1 mice.
Sikorski EE; McCay JA; White KL; Bradley SG; Munson AE
Fundam Appl Toxicol; 1989 Nov; 13(4):843-58. PubMed ID: 2695379
[TBL] [Abstract][Full Text] [Related]
18. Biochemical and immunotoxicological alterations following repeated gallium arsenide exposure and their recoveries by meso-2,3-dimercaptosuccinic acid and 2,3-dimercaptopropane 1-sulfonate administration in rats.
Flora SJ; Kumar P
Environ Toxicol Pharmacol; 1996 Dec; 2(4):315-20. PubMed ID: 21781736
[TBL] [Abstract][Full Text] [Related]
19. Gallium arsenide augments antigen processing by peritoneal macrophages for CD4+ helper T cell stimulation.
Hartmann CB; McCoy KL
Toxicol Appl Pharmacol; 1996 Dec; 141(2):365-72. PubMed ID: 8975760
[TBL] [Abstract][Full Text] [Related]
20. Gallium arsenide exposure impairs splenic B cell accessory function.
Gondre-Lewis TA; Hartmann CB; Caffrey RE; McCoy KL
Int Immunopharmacol; 2003 Mar; 3(3):403-15. PubMed ID: 12639818
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
